These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30717901)

  • 1. Conventional Radioiodine Therapy for Differentiated Thyroid Cancer.
    Ylli D; Van Nostrand D; Wartofsky L
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):181-197. PubMed ID: 30717901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodine in the treatment of thyroid cancer.
    Van Nostrand D; Wartofsky L
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):807-22, vii-viii. PubMed ID: 17673129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry and thyroid cancer: the individual dosage of radioiodine.
    Lassmann M; Reiners C; Luster M
    Endocr Relat Cancer; 2010 Sep; 17(3):R161-72. PubMed ID: 20448022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies, Consensus, and Collaboration in the Use of
    Tuttle RM; Ahuja S; Avram AM; Bernet VJ; Bourguet P; Daniels GH; Dillehay G; Draganescu C; Flux G; Führer D; Giovanella L; Greenspan B; Luster M; Muylle K; Smit JWA; Van Nostrand D; Verburg FA; Hegedüs L
    Thyroid; 2019 Apr; 29(4):461-470. PubMed ID: 30900516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer.
    Padma S; Sundaram PS
    J Cancer Res Ther; 2016; 12(3):1109-1113. PubMed ID: 28054519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer.
    Van Nostrand D
    Endocrinol Metab Clin North Am; 2017 Sep; 46(3):783-793. PubMed ID: 28760238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative use of radioiodine (131-I): review of recommendations and guidelines.
    Prpić M; Jukić T; Murgić J; Borić M; Stanicić J; Kusić Z
    Coll Antropol; 2011 Jun; 35(2):587-94. PubMed ID: 21755735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].
    Dietlein M; Eschner W; Grünwald F; Lassmann M; Verburg FA; Luster M
    Nuklearmedizin; 2016 Jun; 55(3):77-89. PubMed ID: 27350004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for radioiodine therapy of differentiated thyroid cancer.
    Luster M; Clarke SE; Dietlein M; Lassmann M; Lind P; Oyen WJ; Tennvall J; Bombardieri E;
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1941-59. PubMed ID: 18670773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone.
    Berg G; Lindstedt G; Suurküla M; Jansson S
    J Endocrinol Invest; 2002 Jan; 25(1):44-52. PubMed ID: 11883865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin in the development and management of differentiated thyroid cancer.
    McLeod DS
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):367-83. PubMed ID: 24891167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of dosimetry in the treatment of differentiated thyroid cancer.
    Lassmann M; Hänscheid H; Verburg FA; Luster M
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):107-15. PubMed ID: 21386785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal.
    Pacini F; Molinaro E; Castagna MG; Lippi F; Ceccarelli C; Agate L; Elisei R; Pinchera A
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4063-8. PubMed ID: 12213846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.
    Mallick U; Harmer C; Yap B; Wadsley J; Clarke S; Moss L; Nicol A; Clark PM; Farnell K; McCready R; Smellie J; Franklyn JA; John R; Nutting CM; Newbold K; Lemon C; Gerrard G; Abdel-Hamid A; Hardman J; Macias E; Roques T; Whitaker S; Vijayan R; Alvarez P; Beare S; Forsyth S; Kadalayil L; Hackshaw A
    N Engl J Med; 2012 May; 366(18):1674-85. PubMed ID: 22551128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)].
    Dietlein M; Dressler J; Eschner W; Grünwald F; Lassmann M; Leisner B; Luster M; Moser E; Reiners C; Schicha H; Schober O; ;
    Nuklearmedizin; 2007; 46(5):213-9. PubMed ID: 17938757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
    Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy for thyroid cancer in the era of risk stratification and alternative targeted therapies.
    Pryma DA; Mandel SJ
    J Nucl Med; 2014 Sep; 55(9):1485-91. PubMed ID: 25134528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
    Lassmann M; Hänscheid H; Reiners C; Thomas SR
    J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.